Safety and Durability of Accelerated Infliximab Dosing Strategies in Pediatric IBD
Objectives: Infliximab (IFX) is commonly used to treat children with inflammatory bowel disease (IBD). We previously reported that patients with extensive disease started on IFX at a dose of 10 mg/kg had greater treatment durability at year one. The aim of this follow‐up study is to assess the long‐...
Gespeichert in:
Veröffentlicht in: | Journal of pediatric gastroenterology and nutrition 2023-08, Vol.77 (2), p.207-213 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!